Gilder Gagnon Howe & Co’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Buy	+40,128	New	+$10.7M	0.12%	111
2024 Q1	–	Sell	-7,527	Closed	-$934K	–	268
2023 Q4	$934K	Sell	7,527 -1	-0%	-$111	0.01%	206
2023 Q3	$873K	Buy	7,528 +25	+0.3%	+$3.05K	0.01%	213
2023 Q2	$881K	Buy	7,503 +1,876	+33%	+$192K	0.01%	231
2023 Q1	$450K	Buy	+5,627	New	+$442K	0.01%	224
2021 Q2	–	Sell	-6,769	Closed	-$521K	–	429
2021 Q1	$521K	Sell	6,769 -14	-0.2%	-$1.02K	﹤0.01%	316
2020 Q4	$407K	Sell	6,783 -363	-5%	-$18.1K	﹤0.01%	288
2020 Q3	$308K	Sell	7,146 -275	-4%	-$11.9K	﹤0.01%	292
2020 Q2	$307K	Buy	7,421 +7,384	+19,957%	+$355K	﹤0.01%	264
2020 Q1	$2K	Buy	37 +15	+68%	+$785	﹤0.01%	275
2019 Q4	$1K	Hold	22	–	–	﹤0.01%	286
2019 Q3	$1K	Buy	+22	New	+$983	﹤0.01%	283